Glasgow, U.K., 6th July 2009 – Bio-Images Research Ltd. today announced that Professor Howard Stevens, Chairman, will speak to members of the pharmaceutical and biotechnology industries attending the 36th Annual Meeting and Exposition of the Controlled Release Society, to be held in Copenhagen, Denmark, 18th – 22nd July 2009.
Professor Steven’s Soapbox Session at the conference on Sunday 19th July, entitled “Breaking Up in the GI Tract”, will focus on Bio-Images more recent endeavours in characterising erosion behaviour of matrix tablets using gamma scintigraphy and pulmonary models for mucociliary clearance.
Gamma scintigraphy is a well established non-invasive imaging technique with numerous applications in the field of drug delivery. The technique is used to assess the in vivo behaviour of novel formulations, and can also be combined with pharmacokinetics. Information from these studies will assist development decision making, including the development of new formulations as well as re-formulation of existing products, and marketing. Bio-Images have particular expertise in solving concerns with ‘problem’ formulations, such as dose dumping and food effects.
Representatives from Bio-Images clinical research team will also attend the 2009 Controlled Release Society (CRS) Annual Meeting, where the company are exhibiting at booth #307.
Bio-Images Research Ltd. was founded in October 2000 as a spin out company from the University of Strathclyde. Bio-Images undertakes early phase clinical studies in volunteers and patient groups, specialising in gamma scintigraphy. Non-invasive scintigraphic imaging is used to monitor the behaviour of oral, nasal, pulmonary and ophthalmic formulations. All studies are fully compliant with ICH-GCP guidelines with all clinical trial supplies manufactured in a GMP facility.
